The automated instrument will deliver accurate cell isolation, cell activation, cell depletion and Dynabeads magnetic beads removal. Credit: Thermo Fisher Scientific / Business Wire.

Thermo Fisher Scientific has launched the new Gibco CTS DynaCellect Magnetic Separation System (DynaCellect) to improve the cell therapy manufacturing process.  

The closed and automated DynaCellect instrument enables accurate cell isolation, cell activation, cell depletion and Dynabeads magnetic beads removal.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It seeks to enable cell therapy developers to smoothly transition from clinical development to commercial manufacturing by offering a scalable, flexible and end-to-end closed system.

The system will help developers ensure that the right cells are isolated, thus reducing shortcomings in manufacturing.

Both DynaCellect and Dynabeads will allow manufacturers to increase the pace of protocol design and commercial production and will also offer multiple and effective therapy options for patients.

Thermo Fisher Scientific cell culture and cell therapy vice-president and general manager Tiffani Manolis said: “The future of cell therapy is bright, and our team is focused on innovations that expedite breakthroughs and, ultimately, help patients.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“DynaCellect helps minimise the potential for errors while accelerating the manufacturing process.

“This allows our customers to commercialise therapies faster and potentially save more lives. It is a perfect example of how our innovations deliver on our commitment to helping our customers make the world healthier.”

The modular feature of the new system enables it to be used either as a standalone device or integrated with the Gibco CTS ROTEA Counterflow Centrifugation System and the Gibco CTS XENON Electroporation System.

Additionally, DynaCellect provides process scalability for autologous and allogeneic workflows.

In March, Thermo Fisher Scientific introduced the Ion Torrent Genexus Dx Integrated Sequencer platform for use in clinical laboratories.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact